Dónal Landers

1.6k total citations
35 papers, 728 citations indexed

About

Dónal Landers is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Dónal Landers has authored 35 papers receiving a total of 728 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 11 papers in Pulmonary and Respiratory Medicine and 10 papers in Oncology. Recurrent topics in Dónal Landers's work include Fibroblast Growth Factor Research (8 papers), HER2/EGFR in Cancer Research (4 papers) and Cancer Genomics and Diagnostics (4 papers). Dónal Landers is often cited by papers focused on Fibroblast Growth Factor Research (8 papers), HER2/EGFR in Cancer Research (4 papers) and Cancer Genomics and Diagnostics (4 papers). Dónal Landers collaborates with scholars based in United Kingdom, Switzerland and United States. Dónal Landers's co-authors include Elaine Kilgour, André Freitas, Neil R. Smith, Paul Frewer, Oskar Wysocki, Wasat Mansoor, David Cunningham, David Ferry, Yee Chao and Paul K. Stockman and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Dónal Landers

31 papers receiving 713 citations

Peers

Countries citing papers authored by Dónal Landers

Since Specialization

Citations

This map shows the geographic impact of Dónal Landers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dónal Landers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dónal Landers more than expected).

Fields of papers citing papers by Dónal Landers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dónal Landers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dónal Landers. The network helps show where Dónal Landers may publish in the future.

Co-authorship network of co-authors of Dónal Landers

This figure shows the co-authorship network connecting the top 25 collaborators of Dónal Landers. A scholar is included among the top collaborators of Dónal Landers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dónal Landers. Dónal Landers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Translating the machine; An assessment of clinician understanding of ophthalmological artificial intelligence outputs 2025 ·International Journal of Medical Informatics ·Oskar Wysocki, (unknown), Hannah Frost, Donna M. Graham, Dónal Landers, Tariq Aslam	0
2	NLI4CT: Multi-Evidence Natural Language Inference for Clinical Trial Reports 2023 ·Research Explorer (The University of Manchester) ·(unknown), (unknown), Hannah Frost, (unknown), Dónal Landers, André Freitas	2
3	A systematic review of biologically-informed deep learning models for cancer: fundamental trends for encoding and interpreting oncology data 2023 ·BMC Bioinformatics ·Magdalena Wysocka, Oskar Wysocki, Marie Zufferey, Dónal Landers, André Freitas	32
4	SemEval-2023 Task 7: Multi-Evidence Natural Language Inference for Clinical Trial Data 2023 ·Research Explorer (The University of Manchester) ·(unknown), (unknown), Hannah Frost, (unknown), Dónal Landers, André Freitas	23
5	Meta-analysis informed machine learning: Supporting cytokine storm detection during CAR-T cell Therapy 2023 ·Journal of Biomedical Informatics ·(unknown), Magdalena Wysocka, Oskar Wysocki, (unknown), Manon Pillai, Jennifer Allison, Dónal Landers, Elaine Kilgour, Fiona Thistlethwaite, André Freitas	19
6	Digital ECMT Cancer Trial Matching Tool: an Open Source Research Application to Support Oncologists in the Identification of Precision Medicine Clinical Trials 2023 ·JCO Clinical Cancer Informatics ·(unknown), (unknown), (unknown), Julie-Anne Stevenson, Hannah Frost, Donna M. Graham, Matthew Krebs, André Freitas, Dónal Landers	5
7	Patient attrition in Molecular Tumour Boards: a systematic review 2022 ·British Journal of Cancer ·Hannah Frost, Donna M. Graham, Louise Carter, (unknown), Dónal Landers, André Freitas	5
8	Assessing the communication gap between AI models and healthcare professionals: Explainability, utility and trust in AI-driven clinical decision-making 2022 ·Artificial Intelligence ·Oskar Wysocki, (unknown), Markel Vigo, Anne Armstrong, Dónal Landers, Rebecca Lee, André Freitas	61
9	Research Evaluation Alongside Clinical Treatment in COVID-19 (REACT COVID-19): an observational and biobanking study 2021 ·BMJ Open ·Hannah Burke, (unknown), Ahilanandan Dushianthan, Michael Celinski, James Batchelor, Hang Phan, Florina Borca, (unknown), Gareth J. Thomas, Saul N. Faust, (unknown), Sarah Williams, Paul Fitzpatrick, Dónal Landers, Tom Wilkinson	13
10	Wave comparisons of clinical characteristics and outcomes of COVID-19 admissions - Exploring the impact of treatment and strain dynamics 2021 ·Journal of Clinical Virology ·Anna Freeman, Alastair Watson, (unknown), Oskar Wysocki, Hannah Burke, André Freitas, (unknown), Ahilanandan Dushianthan, Michael Celinski, James Batchelor, Hang Phan, Florina Borca, Paul Fitzpatrick, Dónal Landers, Tom Wilkinson	12
11	A Phase Ib Open-Label Multicenter Study of AZD4547 in Patients with Advanced Squamous Cell Lung Cancers 2017 ·Clinical Cancer Research ·Paul K. Paik, Ronglai Shen, Michael F. Berger, David Ferry, Jean‐Charles Soria, Alastair Mathewson, Claire Rooney, Neil R. Smith, Marie Cullberg, Elaine Kilgour, Dónal Landers, Paul Frewer, Nigel Brooks, Fabrice André	115
12	Safety, tolerability and pharmacokinetics of the fibroblast growth factor receptor inhibitor AZD4547 in Japanese patients with advanced solid tumours: a Phase I study 2017 ·Investigational New Drugs ·Hideo Saka, Chiyoe Kitagawa, Yoshihito Kogure, Yasuo Takahashi, Koshi Fujikawa, Tamotsu Sagawa, Satoru Iwasa, Naoki Takahashi, Taro Fukao, (unknown), Dónal Landers, Yasuhide Yamada	48
13	A randomized, open-label study of the efficacy and safety of AZD4547 monotherapy versus paclitaxel for the treatment of advanced gastric adenocarcinoma with FGFR2 polysomy or gene amplification 2017 ·Annals of Oncology ·Eric Van Cutsem, Yu Jeong Bang, Wasat Mansoor, Russell Petty, Yee Chao, David Cunningham, D. Ferry, Neil R. Smith, Paul Frewer, Jayantha Ratnayake, Paul K. Stockman, Elaine Kilgour, Dónal Landers	149
14	Development and Evaluation of a New Technological Way of Engaging Patients and Enhancing Understanding of Drug Tolerability in Early Clinical Development: PROACT 2016 ·Advances in Therapy ·Andrew Hughes, Dónal Landers, Hendrik‐Tobias Arkenau, (unknown), Richard Stephens, (unknown), Matthew N. Simmons, Charlotte Lemech, (unknown)	3
15	BISCAY, a phase Ib, biomarker-directed multidrug umbrella study in patients with metastatic bladder cancer. 2016 ·Journal of Clinical Oncology ·Thomas Powles, Elaine Kilgour, (unknown), (unknown), Hendrik‐Tobias Arkenau, (unknown), Jonathan I. Wilde, Jayantha Ratnayake, Dónal Landers	9
16	FIESTA: A phase Ib and pharmacokinetic trial of AZD4547 in combination with gemcitabine and cisplatin. 2016 ·Journal of Clinical Oncology ·Robert H. Jones, David Alan Anthoney, Robert J. Jones, Simon J. Crabb, Syed A. Hussain, Alison Birtle, Pavlina Spiliopoulou, Tim Robinson, Margaret A. Knowles, Lyndall McLellan, Hazel Jones, (unknown), Dónal Landers, Kwame N. Atuah, (unknown), Sarah Brown, Louise Flanagan, Paul M. Loadman, Chris Twelves, John Chester	2
17	Complexity of FGFR signalling in metastatic urothelial cancer 2015 ·Journal of Hematology & Oncology ·Alejo Rodríguez‐Vida, Matilde Saggese, Simon Hughes, Sarah Rudman, Simon Chowdhury, Neil R. Smith, Peter J. Lawrence, Claire Rooney, Brian Dougherty, Dónal Landers, Elaine Kilgour, Hendrik‐Tobias Arkenau	23
18	A phase 1 expansion cohort of the fibroblast growth factor receptor (FGFR) inhibitor AZD4547 in patients (pts) with advanced gastric (GC) and gastroesophageal (GOJ) cancer. 2014 ·Journal of Clinical Oncology ·Hendrik‐Tobias Arkenau, Matilde Saggese, Antoine Hollebecque, Alastair Mathewson, Charlotte Lemech, Dónal Landers, Paul Frewer, Elaine Kilgour, Nigel Brooks	16
19	Abstract LB-146: A phase II randomized placebo-controlled study of AZD8931, an inhibitor of EGFR, HER2, and HER3 signaling, plus paclitaxel (P) vs P alone in patients (pts) with low HER2-expressing advanced breast cancer (BC) (THYME). 2013 ·Cancer Research ·José Baselga, Roberto Hegg, (unknown), Tatiana Vidaurre, Aňa Lluch, (unknown), Helen Mann, Serban Ghiorghiu, Mary Stuart, Dónal Landers, Kenneth S. Thress, Teresa Klinowska, Javier Cortés	7
20	Dapsone induced methaemoglobinaemia 1996 ·International Journal of STD & AIDS ·Dónal Landers, Colleen J. Bergin, Aisling O’Leary, (unknown), Sarah B. Keating, F Mulcahy	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact